Bresso, Italy

Gilles Pain

USPTO Granted Patents = 2 


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2008-2010

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gilles Pain in Metalloproteinase Inhibition

Introduction: Gilles Pain, an accomplished inventor based in Bresso, Italy, has made significant contributions to the field of medicinal chemistry, particularly in the development of metalloproteinase inhibitors. With a total of two patents, his innovative work focuses on compounds that potentially offer therapeutic benefits in the treatment of arthritis and other related conditions.

Latest Patents: Gilles Pain's latest patents include groundbreaking research on derivatives of hydroxamic acid as metalloproteinase inhibitors. This patent describes a compound of formula (I), including its enantiomers, diastereoisomers, and various salt forms, aimed at the treatment or prophylaxis of arthritis in mammals. Additionally, he has introduced oxa- and thiadiazoles as inhibitors of matrix metalloproteinases, with a focus on compounds represented by formulas (IA) or (IB). These inhibitors specifically target enzymes such as MMP9 and MMP12, which are crucial in the pathological processes of various diseases.

Career Highlights: Throughout his career, Gilles Pain has worked for notable companies including Vernalis Limited, where his expertise contributed to the advancement of pharmaceutical research, and Laboratoires Serono S.A., a leader in biopharmaceutical developments. His roles in these organizations have allowed him to influence the direction of innovative treatments in the field of arthritis and beyond.

Collaborations: Gilles Pain has collaborated with esteemed professionals such as Stephen John Davies and Agnes Bombrun. These partnerships have fostered a collaborative spirit that enhances the potential for groundbreaking discoveries in medicinal chemistry.

Conclusion: Gilles Pain stands out as a noteworthy inventor in the realm of metalloproteinase inhibition. His patents not only demonstrate his innovative approach to the treatment of arthritis but also reflect a commitment to advancing medical science. As he continues to explore new avenues for research and development, the contributions of Gilles Pain are likely to impact the pharmaceutical industry significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…